Gland Pharma Limited (NSE:GLAND)
India · Delayed Price · Currency is INR 1,681.90
+4.40 (0.26%)
Mar 10, 2026, 1:49 PM IST
Gland Pharma Market Cap
Gland Pharma has a market cap or net worth of 276.38 billion as of March 9, 2026. Its market cap has increased by 14.95% in one year.
Market Cap
276.38B
Enterprise Value
247.38B
Revenue
61.13B
Ranking
n/a
PE Ratio
32.62
Stock Price
1,681.90
Market Cap Chart
Since November 20, 2020, Gland Pharma's market cap has decreased from 297.10B to 276.38B, a decrease of -6.97%. That is a compound annual growth rate of -1.35%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 9, 2026 | 276.38B | -2.58% |
| Dec 31, 2025 | 283.71B | -3.22% |
| Dec 31, 2024 | 293.15B | -7.51% |
| Dec 29, 2023 | 316.97B | 22.08% |
| Dec 30, 2022 | 259.64B | -59.11% |
| Dec 31, 2021 | 634.96B | 66.20% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Nov 20, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Alkem Laboratories | 661.19B |
| Glenmark Pharmaceuticals | 599.51B |
| Laurus Labs | 554.00B |
| Ipca Laboratories | 379.08B |
| Ajanta Pharma | 373.66B |
| Emcure Pharmaceuticals | 268.42B |
| Wockhardt | 211.17B |
| Piramal Pharma | 201.66B |